People with dementia should be involved in discussions about their care, says NICE
NICE has updated its guidance for the support of people living with dementia.
NICE backed award for physiotherapist helping to improve patients’ quality of life
Laura McNeillie picks up NICE award at Chief Allied Health Professions Officer’s awards
Adding pertuzumab to existing treatments after surgery for early breast cancer not cost effective, says NICE in draft guidance
Women with a type of early breast cancer may not benefit from continuing or starting a drug after having surgery, NICE says in draft guidance.
Therapy offered within one month to prevent PTSD, says NICE
People who have suffered trauma and are at risk of post-traumatic stress disorder (PTSD) should be offered therapy within one month, NICE says in new draft guidance.
Latest news headlines
-
Professor David Haslam is knighted for his services to NHS Leadership
David has been honoured in Her Majesty, the Queen’s birthday honours list to recognise his outstanding achievements in NHS Leadership.
08 June 2018
-
Takeda pioneers NICE’s new service for economic model review
NICE Scientific Advice (NSA) launched a new health economic model review service, PRIMA, in December 2017 and it is already proving to be a valuable resource for model developers.
07 June 2018
-
Life-extending lung cancer drug will be more widely available on the NHS after NICE review
NICE says more people should be able to freely access pembrolizumab, known as Keytruda, after a new trial shows it helps certain adults with lung cancer live more than a year longer.
06 June 2018
-
NICE approves multiple sclerosis drugs after prices are reduced
Reductions to the price of three multiple sclerosis (MS) drugs mean NICE is now able to recommend them for routine NHS funding.
14 May 2018
-
New guidance will help combat drug resistant urinary tract infections, says NICE
NICE has published new guidance to help healthcare professionals optimise the treatment of urinary tract infections (UTIs).
08 May 2018
-
Hundreds of people with blood cancer given more treatment options after NICE recommends three drugs
NICE has recommended three blood cancer drugs, brentuximab vedotin, midostaurin and arsenic trioxide be made available on the NHS.
04 May 2018